ID

42068

Description

Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin

Mots-clés

  1. 08/07/2018 08/07/2018 -
  2. 21/07/2018 21/07/2018 -
  3. 18/08/2018 18/08/2018 -
  4. 15/03/2021 15/03/2021 - Dr. rer. medic Philipp Neuhaus
Détendeur de droits

GlaxoSmithKline

Téléchargé le

15 mars 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593

Prior Therapy

  1. StudyEvent: ODM
    1. Prior Therapy
Prior Therapy
Description

Prior Therapy

Alias
UMLS CUI-1
C1514463
Series page
Description

undefined item

Type de données

text

Alias
UMLS CUI [1,1]
C0205549
UMLS CUI [1,2]
C1704732
Last page
Description

Last page

Type de données

boolean

Alias
UMLS CUI [1,1]
C1704732
UMLS CUI [1,2]
C1517741
Drugs
Description

Drugs

Alias
UMLS CUI-1
C0013227
Chemotherapy Code
Description

Chemotherapy Code

Type de données

text

Alias
UMLS CUI [1,1]
C3665472
UMLS CUI [1,2]
C0805701
Drugs
Description

List drug names only if code is not given

Type de données

text

Alias
UMLS CUI [1]
C0013227
Therapy Start Date (mm/dd/yy)
Description

Start Date

Type de données

date

Alias
UMLS CUI [1]
C3173309
Therapy Stop Date (mm/dd/yy)
Description

End Date

Type de données

date

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0806020
Number of Cycles
Description

Chemotherapy cycle; Count of entities

Type de données

integer

Alias
UMLS CUI [1,1]
C1302181
UMLS CUI [1,2]
C0237753
Therapy Outcome
Description

Outcome of Therapy

Type de données

text

Alias
UMLS CUI [1]
C1518681
Duration of Response (months)
Description

Response Duration

Type de données

integer

Unités de mesure
  • months
Alias
UMLS CUI [1]
C0237585
months
Prior Radiation Therapy
Description

Prior Radiation Therapy

Alias
UMLS CUI-1
C1522449
UMLS CUI-2
C0332152
Therapy Start Date (mm/dd/yy)
Description

Start Date

Type de données

date

Alias
UMLS CUI [1]
C3173309
Therapy Stop Date (mm/dd/yy)
Description

End Date

Type de données

date

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0806020
Total Dose in cGY
Description

radiation therapy pattern total dose (___cGy)

Type de données

float

Unités de mesure
  • cGy
Alias
UMLS CUI [1]
C2169193
cGy
Location (sites treated)
Description

Location; Therapeutic procedure

Type de données

text

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0450429
Therapy Outcome at Irradiated Location
Description

irradiation site; Outcome of Therapy

Type de données

text

Alias
UMLS CUI [1,1]
C2169202
UMLS CUI [1,2]
C1518681
Duration of Response (months)
Description

Duration of Response

Type de données

text

Alias
UMLS CUI [1]
C0237585

Similar models

Prior Therapy

  1. StudyEvent: ODM
    1. Prior Therapy
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Prior Therapy
C1514463 (UMLS CUI-1)
undefined item
Item
Series page
text
C0205549 (UMLS CUI [1,1])
C1704732 (UMLS CUI [1,2])
Last page
Item
Last page
boolean
C1704732 (UMLS CUI [1,1])
C1517741 (UMLS CUI [1,2])
Item Group
Drugs
C0013227 (UMLS CUI-1)
Item
Chemotherapy Code
text
C3665472 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
Code List
Chemotherapy Code
CL Item
CVP (1)
CL Item
C-MOPP (2)
CL Item
BACOP (3)
CL Item
COP- Bleo (4)
CL Item
CHOP (5)
CL Item
CHOP- Bleo (6)
CL Item
CP (7)
CL Item
Cytoxan (8)
CL Item
COPP (9)
CL Item
Pro- MACE- MOPP (10)
CL Item
CHOP- Bleo + Alpha Interferon (11)
CL Item
COMLA (12)
CL Item
Fludarabine (13)
CL Item
ACP (14)
CL Item
MINE (15)
CL Item
ESHAP (16)
CL Item
DHAP (17)
CL Item
EPOCH (18)
CL Item
CEPP (19)
CL Item
Pro- MACE- CytaBOM (20)
CL Item
ICE (21)
CL Item
COP- BLAM (22)
CL Item
CNOP (23)
CL Item
FND (24)
CL Item
MACOP- B (25)
CL Item
m- BACOD (26)
CL Item
VAPEC- B (27)
CL Item
IM- VP 16 (28)
CL Item
CF (29)
CL Item
Other (specify) (30)
CL Item
Chlorambucil (49)
CL Item
Rituximab (64)
Pharmaceutical Preparations
Item
Drugs
text
C0013227 (UMLS CUI [1])
Start Date
Item
Therapy Start Date (mm/dd/yy)
date
C3173309 (UMLS CUI [1])
End Date
Item
Therapy Stop Date (mm/dd/yy)
date
C0087111 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Chemotherapy cycle; Count of entities
Item
Number of Cycles
integer
C1302181 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Item
Therapy Outcome
text
C1518681 (UMLS CUI [1])
Code List
Therapy Outcome
CL Item
PD (1)
(Comment:en)
CL Item
SD (2)
(Comment:en)
CL Item
PR (3)
(Comment:en)
CL Item
CCR (4)
(Comment:en)
CL Item
CR (5)
(Comment:en)
CL Item
Unknown (0)
(Comment:en)
Response Duration
Item
Duration of Response (months)
integer
C0237585 (UMLS CUI [1])
Item Group
Prior Radiation Therapy
C1522449 (UMLS CUI-1)
C0332152 (UMLS CUI-2)
Start Date
Item
Therapy Start Date (mm/dd/yy)
date
C3173309 (UMLS CUI [1])
End Date
Item
Therapy Stop Date (mm/dd/yy)
date
C0087111 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
radiation therapy pattern total dose (___cGy)
Item
Total Dose in cGY
float
C2169193 (UMLS CUI [1])
Location; Therapeutic procedure
Item
Location (sites treated)
text
C0087111 (UMLS CUI [1,1])
C0450429 (UMLS CUI [1,2])
Item
Therapy Outcome at Irradiated Location
text
C2169202 (UMLS CUI [1,1])
C1518681 (UMLS CUI [1,2])
Code List
Therapy Outcome at Irradiated Location
CL Item
PD (1)
CL Item
SD (2)
CL Item
PR (3)
CL Item
CCR (4)
CL Item
CR (5)
CL Item
Unknown (0)
Duration of Response
Item
Duration of Response (months)
text
C0237585 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial